Join to view full profile
125 Red Creek DrRochester, NY 14623
Phone+1 585-486-0600
Fax+1 585-486-0649
Dr. Falkson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Carla Falkson is an oncologist based in Rochester, NY, specializing in breast cancer. She completed a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. Dr. Falkson is experienced in immunotherapy, prostate cancer, personalized medicine, medical oncology, and breast pathology. Her research work includes numerous publications, such as studies on therapies for hormone receptor-positive and early-stage breast cancer. She has been involved in various clinical trials related to breast cancer, melanoma, acute myeloid leukemia, and liver cancer. Dr. Falkson has received the Unsung Hero Award from the Division of Hematology Oncology at UAB and has received multiple certifications for CMS Meaningful Use Stages.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
University of Pretoria Faculty of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 2019 - 2027
AL State Medical License 2000 - 2019
Awards, Honors, & Recognition
- Unsung Hero Award Division of hematology Oncology Dept Medicine UAB, 2018
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014, 2016-2017
Clinical Trials
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
- Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Publications & Presentations
PubMed
- Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.Claudine Isaacs, Rita Nanda, Christina Yau, A Jo Chien, Dawn L Hershman
JAMA Oncology. 2026-09-01 - 7 citationsA Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELE...Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson
Clinical Cancer Research. 2025-07-01 - 2 citationsOptimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of D...Dario Trapani, Qingchun Jin, Kathy D Miller, Hope S Rugo, Katherine E Reeder-Hayes
Clinical Breast Cancer. 2025-06-01
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
- Breast Cancer and the COVID Vaccine: What You Need to KnowMarch 1st, 2021
Guided by Research, Wilmot’s Breast Cancer Program Comes of AgeOctober 19th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
